Terms: = Lung cancer AND KIT, C-Kit, 3815, ENSG00000157404, CD117, SCFR, P10721 AND Staging
43 results:
1. HBB as a Novel Biomarker for the Diagnosis and Monitoring of lung cancer Regulates Cell Proliferation via ERK1/2 Pathway.
Xu X; Cai H; Peng J; Liu H; Chu F
Technol Cancer Res Treat; 2024; 23():15330338241249032. PubMed ID: 38679728
[No Abstract] [Full Text] [Related]
2. Two Interventions on Pathologic Nodal staging in a Population-Based lung cancer Resection Cohort.
Osarogiagbon RU; Ray MA; Fehnel C; Akinbobola O; Saulsberry A; Dortch K; Faris NR; Matthews AT; Smeltzer MP; Spencer D;
Ann Thorac Surg; 2024 Mar; 117(3):576-584. PubMed ID: 37678613
[TBL] [Abstract] [Full Text] [Related]
3. Circulating exosomal microRNA-4497 as a potential biomarker for metastasis and prognosis in non-small-cell lung cancer.
Zheng B; Peng M; Gong J; Li C; Cheng H; Li Y; Tang Y
Exp Biol Med (Maywood); 2023 Aug; 248(16):1403-1413. PubMed ID: 37551102
[TBL] [Abstract] [Full Text] [Related]
4. IncRNA EPB41L4A-AS1 Mitigates the Proliferation of Non-Small-Cell lung cancer Cells through the miR-105-5p/GIMAP6 Axis.
Dong B; Zhang F; Zhang W; Gao Y
Crit Rev Eukaryot Gene Expr; 2023; 33(2):27-40. PubMed ID: 36734855
[TBL] [Abstract] [Full Text] [Related]
5. LncRNA MATN1-AS1 for Prediction of Prognosis in Osteosarcoma Patients and Its Cellular Function.
Liu Y; Wang D; Ji Q; Yan J
Mol Biotechnol; 2022 Jan; 64(1):66-74. PubMed ID: 34542816
[TBL] [Abstract] [Full Text] [Related]
6. Outcomes After Use of a Lymph Node Collection kit for lung cancer Surgery: A Pragmatic, Population-Based, Multi-Institutional, Staggered Implementation Study.
Osarogiagbon RU; Smeltzer MP; Faris NR; Ray MA; Fehnel C; Ojeabulu P; Akinbobola O; Meadows-Taylor M; McHugh LM; Halal AM; Levy P; Sachdev V; Talton D; Wiggins L; Shu XO; Shyr Y; Robbins ET; Klesges LM
J Thorac Oncol; 2021 Apr; 16(4):630-642. PubMed ID: 33607311
[TBL] [Abstract] [Full Text] [Related]
7. Comparative Effectiveness of a Lymph Node Collection kit Versus Heightened Awareness on lung cancer Surgery Quality and Outcomes.
Ray MA; Fehnel C; Akinbobola O; Faris NR; Taylor M; Pacheco A; Smeltzer MP; Osarogiagbon RU
J Thorac Oncol; 2021 May; 16(5):774-783. PubMed ID: 33588112
[TBL] [Abstract] [Full Text] [Related]
8. MiR-587 acts as an oncogene in non-small-cell lung carcinoma via reducing CYLD expression.
Li XJ; Chen LW; Gao P; Jia YJ
Eur Rev Med Pharmacol Sci; 2020 Dec; 24(24):12741-12747. PubMed ID: 33378022
[TBL] [Abstract] [Full Text] [Related]
9. MiR-1471 protects the aggravation of non-small-cell lung carcinoma by targeting FOXL1.
Shi D; Zhang K; Li G; Zhao Y
Biofactors; 2020 Sep; 46(5):734-742. PubMed ID: 33045131
[TBL] [Abstract] [Full Text] [Related]
10. MicroRNA-597 inhibits NSCLC progression through negatively regulating CDK2 expression.
Yu DJ; Li YH; Zhong M
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(8):4288-4297. PubMed ID: 32373965
[TBL] [Abstract] [Full Text] [Related]
11. USP3 promotes proliferation of non-small cell lung cancer through regulating RBM4.
Liao XH; Wang Y; Zhong B; Zhu SY
Eur Rev Med Pharmacol Sci; 2020 Mar; 24(6):3143-3151. PubMed ID: 32271432
[TBL] [Abstract] [Full Text] [Related]
12. MiRNA-200a-3p suppresses the proliferation, migration and invasion of non-small cell lung cancer through targeting IRS2.
Tan T; Xu XH; Lu XH; Wang XW
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):712-720. PubMed ID: 32016973
[TBL] [Abstract] [Full Text] [Related]
13. MAGI1-IT1 stimulates proliferation in non-small cell lung cancer by upregulating AKT1 as a ceRNA.
Zhang G; Chen HX; Yang SN; Zhao J
Eur Rev Med Pharmacol Sci; 2020 Jan; 24(2):691-698. PubMed ID: 32016970
[TBL] [Abstract] [Full Text] [Related]
14. MicroRNA‑936 inhibits the malignant phenotype of retinoblastoma by directly targeting HDAC9 and deactivating the PI3K/AKT pathway.
Xu L; Li W; Shi Q; Wang M; Li H; Yang X; Zhang J
Oncol Rep; 2020 Feb; 43(2):635-645. PubMed ID: 31922233
[TBL] [Abstract] [Full Text] [Related]
15. Programmed Death Ligand 1 Testing of Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Samples Acquired For the Diagnosis and staging of Non-Small Cell lung cancer.
Smith A; Wang H; Zerbo A; Beaudoin S; Ofiara L; Fiset PO; Benedetti A; Gonzalez AV
J Bronchology Interv Pulmonol; 2020 Jan; 27(1):50-57. PubMed ID: 31513030
[TBL] [Abstract] [Full Text] [Related]
16. MicroRNA-16 inhibits the proliferation, migration and invasion of non-small cell lung carcinoma cells by down-regulating matrix metalloproteinase-19 expression.
Tian G; Wang SW; Song M; Hu YF; Cao XN; Ge JW
Eur Rev Med Pharmacol Sci; 2019 Jun; 23(12):5260-5269. PubMed ID: 31298377
[TBL] [Abstract] [Full Text] [Related]
17. LncRNA BX357664 inhibits the proliferation and invasion of non-small cell lung cancer cells.
Yang J; Du YM; Li B
Eur Rev Med Pharmacol Sci; 2019 Jan; 23(2):660-669. PubMed ID: 30720174
[TBL] [Abstract] [Full Text] [Related]
18. MiR‑495 suppresses cell proliferation by directly targeting HMGA2 in lung cancer.
Sun J; Qiao Y; Song T; Wang H
Mol Med Rep; 2019 Mar; 19(3):1463-1470. PubMed ID: 30569167
[TBL] [Abstract] [Full Text] [Related]
19. Can the One-Step Nucleic Acid Amplification method of lymph nodes examination make the staging of pulmonary tumours more precise?
Vodička J; Vejvodová Š; Pešta M; Mukenšnabl P; Špidlen V; Kulda V; Houfková K; Topolčan O
Rozhl Chir; 2018; 97(8):373-378. PubMed ID: 30441990
[TBL] [Abstract] [Full Text] [Related]
20. Effectiveness of Implemented Interventions on Pathologic Nodal staging of Non-Small Cell lung cancer.
Ray MA; Faris NR; Smeltzer MP; Fehnel C; Houston-Harris C; Levy P; Wiggins L; Sachdev V; Robbins T; Spencer D; Osarogiagbon RU
Ann Thorac Surg; 2018 Jul; 106(1):228-234. PubMed ID: 29534956
[TBL] [Abstract] [Full Text] [Related]
[Next]
